Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an essential mineral that plays a vital role in numerous biochemical processes, including neuromuscular function, cardiac rhythm, and protein synthesis. It is available in intravenous (IV) and intramuscular (IM) formulations.
## Primary Indications
* **Hypomagnesemia:** Treatment of magnesium deficiency.
* **Eclampsia and Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia.
* **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia associated with a prolonged QT interval.
* **Bronchodilator (Adjunct):** In severe, refractory asthma exacerbations.
* **Refractory Ventricular Tachycardia:** In the absence of a prolonged QT interval, particularly in patients with suspected hypomagnesemia.
## Adult Dosing
* **Hypomagnesemia:**
* **Severe Deficiency (Serum Magnesium < 1.3 mEq/L or < 0.65 mmol/L):** 4-5 grams (32-40 mEq or 16-20 mmol) IV infused over 10-20 minutes, followed by a continuous infusion of 1-2 grams (8-16 mEq or 4-8 mmol) per hour until serum magnesium normalizes.
* **IM Administration:** 1 gram (8 mEq or 4 mmol) IM every 4-6 hours for 4 doses.
* **Eclampsia/Preeclampsia:**
* **Loading Dose:** 4-6 grams (32-48 mEq or 16-24 mmol) IV infused over 5-10 minutes.
* **Maintenance Dose:** 1-2 grams (8-16 mEq or 4-8 mmol) per hour IV infusion. Dosing may be adjusted based on clinical response and serum magnesium levels; local protocols should be followed.
* **Torsades de Pointes:** 1-2 grams (8-16 mEq or 4-8 mmol) IV as a bolus infused over 5-10 minutes, followed by an infusion of 1 gram (8 mEq or 4 mmol) per hour.
* **Asthma (Adjunct):** 1-2 grams (8-16 mEq or 4-8 mmol) IV infused over 15-20 minutes.
## Pediatric Dosing
Dosing in pediatrics is highly variable and dependent on the indication and patient weight.
* **Hypomagnesemia:** Typical doses range from 25-50 mg/kg/dose (elemental magnesium) IV or IM over 10 minutes to several hours, not to exceed 1 gram (8 mEq or 4 mmol) per dose. Maintenance infusions may be required.
* **Eclampsia:** Dosing is based on adult guidelines but may be adjusted for pediatric patients. Specific protocols are essential.
* **Torsades de Pointes:** 25-100 mg/kg/dose (elemental magnesium) IV, maximum 2 grams (16 mEq or 8 mmol) per dose. Infusion rate typically over 10-30 minutes.
**Note:** Pediatric dosing requires careful calculation of elemental magnesium and adherence to specific protocols.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. In patients with severe renal impairment, doses should be reduced, and serum magnesium levels should be closely monitored to prevent hypermagnesemia.
## Contraindications
* **Hypermagnesemia:** Elevated serum magnesium levels.
* **Heart Block:** Second- or third-degree atrioventricular (AV) block without a pacemaker.
* **Myocardial Infarction (MI):** In patients with a history of MI, especially if accompanied by conduction abnormalities.
* **Hypersensitivity:** Known hypersensitivity to magnesium sulfate.
## Adverse Effects
* **Common:** Flushing, warmth, hypotension, drowsiness, nausea, vomiting, decreased reflexes, decreased respiratory rate.
* **Serious:** Cardiac arrhythmias, cardiac arrest, respiratory depression, coma, hypothermia, muscle paralysis.
## Key Drug Interactions
* **Neuromuscular Blockers (e.g., succinylcholine, vecuronium):** Magnesium sulfate can potentiate neuromuscular blockade, increasing the risk of prolonged respiratory paralysis.
* **Calcium Channel Blockers:** Additive hypotensive effects and potential for enhanced neuromuscular blockade.
* **Antibiotics (Tetracyclines, Fluoroquinolones):** Magnesium can decrease the absorption of oral tetracyclines and fluoroquinolones; administer at least 2 hours before or 4-6 hours after magnesium.
* **Bisphosphonates:** May reduce the absorption of bisphosphonates.
## Monitoring
* **Serum Magnesium Levels:** Essential, especially with IV infusions and in patients with renal impairment. Target levels vary by indication (e.g., 4-7 mEq/L for eclampsia).
* **Renal Function:** Monitor creatinine and BUN.
* **Deep Tendon Reflexes:** Diminished reflexes can indicate hypermagnesemia.
* **Respiratory Rate and Effort:** Respiratory depression is a sign of toxicity.
* **Blood Pressure and Heart Rate:** Monitor for hypotension and cardiac effects.
* **Urine Output:** Adequate urine output is necessary for magnesium excretion.
## Clinical Pearls
* Always calculate and administer magnesium sulfate based on elemental magnesium content (mEq or mmol).
* IV infusion rates should be controlled to prevent rapid increases in serum magnesium, which can cause hypotension and cardiac depression.
* Ensure antidote (calcium gluconate) is readily available for signs of magnesium toxicity.
* For IM administration, use large muscle groups and divide doses if necessary to minimize pain and induration.
* In patients with renal dysfunction, dose reductions are crucial, and frequent monitoring of serum magnesium is mandatory.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information, institutional protocols, and patient-specific factors before administering any medication.
